NCT01552044View on ClinicalTrials.gov

Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions
Central Serous Chorioretinitis
Interventions
DRUG

Spironolactone

25mg tablet once a day for 1 month

DRUG

Placebo

one tablet once a day for 1 month

Trial Locations (1)

75004

Hotel-Dieu of Paris, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01552044 - Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis | Biotech Hunter | Biotech Hunter